Advanced PET Imaging, Nuclear Medicine, and Therapy: From Diagnostics to Theranostics 2025

Start:

Sun, 20 Apr 2025, 09:00

End:

Sun, 20 Apr 2025, 06:00

Website:

https://iii.hm/petimaging2025

Venue:

Find CME On Social Media

Exhibit

Symposia

Workshops

Organiser

Sponsor

This course provides a clinical perspective of PET/CT imaging and the emerging use of Theranostic agents within Nuclear Medicine. A broad perspective on the economic, clinical, and academic aspects of the latest trends in PET/CT imaging and Nuclear Medicine therapy will be presented.

At the conclusion of this course, participants will be able to:

Describe new developments in the merger of diagnostic and therapeutic radioligands for PET/CT imaging and therapy with specific focus on DOTA, PSMA, and PRRT
Describe the logistics of bringing these new diagnostic and therapeutic technologies to clinical practice
Identify the key clinical indications for new emerging tracers for Neuroendocrine Tumor and Prostate cancer using somatostatin receptor and PSMA PET/CT imaging
Review and discuss the standard-of-care clinical application and advanced interpretation of FDG PET/CT

With the recent approval by CMS Medicare for DOTATATE (NETSPOT) PET/CT and the rapid international adoption of targeted Lu-177 based therapies for neuroendocrine and prostate cancers, it is clear that Nuclear Medicine and PET/CT are entering into a new era. New diagnostic and therapeutic agents with remarkable sensitivity and specificity are revolutionizing Nuclear Medicine and Oncology. This course will highlight the latest targeted imaging agents for neuroendocrine and prostate cancers (Ga-68 DOTATATE and Ga-68 PSMA PET/CT) as well as review important core concepts in PET/CT imaging and therapeutic Nuclear Medicine.

Target Audience

This course is intended for practicing radiologists, nuclear medicine physicians and radiologic nurses, physician assistants, technologists, residents, fellows and others who are interested in the clinical applications of PET and PET/CT.

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and CME Science. PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

PACE designates this live activity for 16.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest

PACE requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships are mitigated according to PACE policies.

Technologists: This course is pending approval for up to 16 ARRT Category A CE credits for those technologists attending the entire course (pending courses are always approved but the official language requires we use “pending approval” until closer to the course start date).

In-Person attendees have the option of being in the meeting room or viewing the live broadcast from their guest rooms, or any space with WI-Fi.

All Registrants, In-Person and Live Webinar have access to the webinar for four months.

Standard Registration-Physicians MD/DO	$1,495.00
Nurses/Advanced Practice Professionals/Retired/Active Military	$1,395.00
Radiologic Technologists/Residents/Fellows	$1,295.00

*Residents and Fellows – after registering, please fax proof of your residency/fellowship to 1-650-887-2113 or email [email protected]

Cancellation Policy

IN PERSON REGISTRATION

Cancellations received at least 30 days in advance are subject to a $100 cancellation fee or may be exchanged for their full value for a voucher for future use for any live, webinar, or on-demand course that takes place within 13 months of the canceled course. Cancellations received less than 30 days before the start of the course are non-refundable but may be exchanged for their full value for a voucher for future use for any live, webinar, or on-demand course that takes place within 13 months of the canceled course.

WEBINARREGISTRATION

Cancellations received at least 21 days in advance are subject to a $100 cancellation fee or may be exchanged for their full value for a voucher for future use for any live, webinar, or on-demand course that takes place within 13 months of the canceled course. Cancellations received less than 21 days before the start of the course are non-refundable but may be exchanged for their full value for a voucher for future use for any live, webinar, or on-demand course that takes place within 13 months of the canceled course.

Webinar access is available for 4 months after the conclusion of the live presentations. CME credit must be claimed within 1 month after the course concludes.

Webinar access is strictly for the registrant only. Sharing access without permission may void your CME eligibility and/or close your access and is a violation of your purchase agreement. If you would like to share access, please contact us.

In-Person Registration

Webinar Registration

Thursday, October 16, 2025

Time	Session	Speaker
7:30-8:00 AM	Check-In and Continental Breakfast
8:00-8:45	Introduction to Theranostics	Phillip Kuo, MD, PhD
8:45-9:45	Update on Radioiodine Treatment for Thyroid Cancer and the Role of PET/CT	Don C. Yoo, MD
9:45-10:00	Questions and Answers, Coffee Service
10:00-11:00	Importance of Patient Preparation for PET/CT (Oncology and Cardiac Sarcoidosis)	Don C. Yoo, MD
11:00-11:45	PET/CT in Head and Neck Cancer	Don C. Yoo, MD
11:45-12:00	Questions and Answers
12:00-1:00 PM	Break for Lunch on Own
1:00-2:00	Menu of New PET Tracers	Andrew Quon, MD
2:00-2:45	Case-based Review of PET/CT for Amyloid Imaging	Phillip Kuo, MD, PhD
2:45-3:00	Questions and Answers, Coffee Service
3:00-3:45	DOTATATE PET and PRRT	Andrew Quon, MD
3:45-4:30	Update on Nuclear Medicine for Infection and Inflammation	Don C. Yoo, MD
4:30-5:15	PSMA PET Scanning and Therapy	Andrew Quon, MD
5:15-5:30	Discussion, Questions and Answers

October 17, 2025

Time	Session	Speaker
7:30-8:00 AM	Check-In and Continental Breakfast
8:00-9:00	Understanding the Role of PSMA-PET in Selecting Patients for PSMA-Targeted Therapy	Phillip Kuo, MD, PhD
9:00-9:45	Challenging and Instructive Abdomen and Pelvis PET/CT Rev	Don C. Yoo, MD
9:45-10:00	Questions and Answers, Coffee Service
10:00-10:45	Pearls and Pitfalls for FDG-PET	Phillip Kuo, MD, PhD
10:45-11:30	Challenging and Instructive Chest PET/CT Review	Don C. Yoo, MD
11:30-12:15	PET Imaging for the Differential Diagnosis of Dementia	Phillip Kuo, MD, PhD
12:15-12:30	Questions and Answers
12:30-1:30 PM	Break for Lunch
1:30-2:30	Dopamine Transporter Imaging of Parkinsonian Syndromes	Phillip Kuo, MD, PhD
2:30-3:15	PSMA PET Optimizing Therapy Resonse Assessment	Don C. Yoo, MD
315-4:15	Amyloid and Tau Brain PET rebooted: The New Era of Neurotheranostics for Dementia	Phillip Kuo, MD, PhD
4:15-4:45	Discussion, Questions and Answers